The mortality rate for malignant neoplasms of the colon, rectum, and anus in Japan is forecasted to increase from 39.7 deaths per hundred thousand women in 2024 to 41.7 in 2028. This reflects a year-on-year growth rate of approximately 1.3% over the forecast period. The compounded annual growth rate (CAGR) from 2024 to 2028 is expected to be about 1.3%, indicating a steady upward trend. However, precision in forecasting does require attention to the fact that 2023 mortality figures are not provided, which would offer a clearer baseline for comparison.
Future trends to watch for include advances in medical technology and cancer treatment, potential healthcare policy changes in Japan, and shifts in lifestyle or demographic factors among women that may influence cancer incidence and mortality rates. Continuous monitoring will be necessary to adjust forecasts in response to these developments.
